Keyphrases
Spain
100%
Escherichia Coli
95%
Drosophilidae
60%
Mycobacterium Tuberculosis (M. tb)
60%
Barcelona
47%
Tuberculosis
43%
Drosophila Melanogaster
38%
Fanconi Anemia
36%
Inclusion Bodies
32%
Nanoparticles
29%
DNA Damage
29%
Drosophila Buzzatii
27%
β-Galactosidase (β-Gal)
25%
Mycobacterium
25%
Micronucleus
25%
Genotoxicity
23%
Recombinant Protein
22%
Catalonia
22%
Microorganisms
22%
Bacterial Inclusion Bodies
21%
Virulence
20%
C-X-C Chemokine Receptor Type 4 (CXCR4)
20%
COVID-19
19%
Protein Nanoparticles
19%
Plasmid
19%
Pseudomonas Aeruginosa (P. aeruginosa)
19%
Copyright
18%
Vibrio Parahaemolyticus
18%
β-lactamase
18%
LexA
17%
RecA
17%
Quantitative PCR
16%
Antibiotics
16%
Human Lymphocytes
16%
Genotype
16%
Comet Assay
16%
Polymorphism
16%
Drosophila Subobscura
16%
Recombinant
15%
Salmonella
15%
Confidence Interval
15%
Risk Factors
15%
Microbial Mats
15%
Polypeptide
15%
Active Tuberculosis
15%
Epidemiology
14%
Virus
14%
Transposable Elements
14%
Salmonella Enterica Serovar Typhimurium (S. Typhimurium)
14%
Evolutionary History
13%
Bacteriophage
13%
Gene Expression
13%
Pulsed-field Gel Electrophoresis
13%
Phage
13%
Genotoxic Effect
13%
Klebsiella Pneumoniae (K. pneumoniae)
13%
Biofilm
13%
Lung
13%
Genetic Damage
12%
Latent Tuberculosis Infection
12%
Adaptation
12%
Melanogaster
12%
Europe
11%
Enterobacteriaceae
11%
Acinetobacter Baumannii (A. baumannii)
11%
V. Parahaemolyticus
11%
Antimicrobial
11%
Salmonella Enterica
11%
Mammalian Cells
11%
Multifunctional Protein
11%
Arsenic
10%
Cyanobacteria
10%
Mouse Model
10%
Micronucleus Test
10%
SOS Response
10%
University Hospital
10%
Recombinant Protein Production
10%
Viral
10%
Gene Therapy
10%
Nanomaterials
10%
Molecular Epidemiology
10%
Infectious Diseases
10%
Polymerase Chain Reaction
9%
RecA Gene
9%
Immune Response
9%
Sister Chromatid Exchange
9%
Natural Selection
9%
Nanostructures
9%
Nanoplastics
9%
Rapid Detection
9%
Genetic Diversity
9%
Chromosomal Inversion
9%
Tumor
9%
Gram-negative Bacteria
9%
Genetic Variation
9%
Tuberculin Skin Test
9%
Vaccination
9%
Bacillus
9%
Nanomedicine
9%
Antimicrobial Resistance
8%